Abbott Laboratories




  • EC issues a positive opinion reaffirming the safety and efficacy of Reductil

  • Abbott Laboratories has announced that the European Union's Committee for Proprietary Medicinal Products (CPMP) has completed an extensive review of the safety and efficacy data for Sibutramine (marketed in the Middle East as Reductil), and issued a positive opinion reaffirming its favorable risk/benefit profile in the treatment of obesity.
  • United Arab Emirates: Sunday, July 07 - 2002 at 12:58
  • Abbott launches new sedative in the Middle East

  • Abbott Laboratories has launched a new sedative in the Middle East. The product was launched at a symposium organised by the Saudi Anaesthetic Association in Dubai.
  • United Arab Emirates: Wednesday, July 03 - 2002 at 13:29
  • Omar Abu Sheikha, GM, Abbott Levant (2nd from left) receives the award from Dr. Mamum Ezzibdeh, President of the Congress (2nd right) for Abbott Laboratories' contributions to the 2nd Mediterranean Congress on Sexual Dysfunction.
  • Major healthcare company receives award

  • The 2nd Mediterranean Congress on Sexual Dysfunction, which took place in Amman with the participation of 500 Arab and international doctors, ended on June 28th.
  • United Arab Emirates: Monday, July 01 - 2002 at 16:01


Sponsored Links

MediaCentre »

Business Directory »

News and Articles »

Current Events »

Advertisement »